182 related articles for article (PubMed ID: 38065541)
21. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yu Q; Liu C; Navuluri R; Ahmed O
Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
[TBL] [Abstract][Full Text] [Related]
22. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
[TBL] [Abstract][Full Text] [Related]
23. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
Chong CCN; Lee KF; Cheung SYS; Chu CCM; Fong AKW; Wong J; Hui JWY; Fung AKY; Lok HT; Lo EYJ; Chan SL; Yu SCH; Ng KKC; Lai PBS
HPB (Oxford); 2020 Aug; 22(8):1121-1127. PubMed ID: 32044268
[TBL] [Abstract][Full Text] [Related]
24. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
[TBL] [Abstract][Full Text] [Related]
25. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma.
Ding J; Jing X; Liu J; Wang Y; Wang F; Wang Y; Du Z
Eur J Radiol; 2013 Sep; 82(9):1379-84. PubMed ID: 23726122
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
Miyamoto N; Kanaya M; Fujii T; Kato H; Kudo K; Kinota N
Jpn J Radiol; 2021 Apr; 39(4):376-386. PubMed ID: 33150469
[TBL] [Abstract][Full Text] [Related]
28. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
Simo KA; Sereika SE; Newton KN; Gerber DA
J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
[TBL] [Abstract][Full Text] [Related]
31. The (Eternal) Debate on Microwave Ablation
Ricci AD; Rizzo A; Bonucci C; Tavolari S; Palloni A; Frega G; Mollica V; Tober N; Mazzotta E; Felicani C; Serra C; Brandi G
In Vivo; 2020; 34(6):3421-3429. PubMed ID: 33144450
[TBL] [Abstract][Full Text] [Related]
32. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
33. Comparison of percutaneous microwave ablation and surgical resection for hepatocellular carcinoma in the caudate lobe.
Qi E; Zhang S; Li X; Cheng Z; Han Z; Yu J; Liang P; Yu X
J Cancer Res Ther; 2022 Apr; 18(2):378-383. PubMed ID: 35645103
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
36. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
37. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
38. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems.
Loriaud A; Denys A; Seror O; Vietti Violi N; Digklia A; Duran R; Trillaud H; Hocquelet A
Int J Hyperthermia; 2018 Dec; 34(8):1171-1178. PubMed ID: 29457510
[TBL] [Abstract][Full Text] [Related]
40. Comparison of percutaneous microwave ablation with radiofrequency ablation for hepatocellular carcinoma adjacent to major vessels: A retrospective study.
Shen Q; Wang N; Wu PP; Tan BB; Qian GJ
J Cancer Res Ther; 2022 Apr; 18(2):329-335. PubMed ID: 35645097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
